azelastine hcl nasal (Perrigo New York Inc)
Welcome to the PulseAid listing for the azelastine hcl nasal drug offered from Perrigo New York Inc. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
| NON-PROPRIETARY NAME: | Azelastine HCl |
| SUBSTANCE NAME: | AZELASTINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| ROUTE: | NASAL |
| DOSAGE FORM: | SPRAY |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-05-09 |
| END MARKETING DATE: | 0000-00-00 |
azelastine hcl nasal HUMAN PRESCRIPTION DRUG Details:
| Item Description | azelastine hcl nasal from Perrigo New York Inc |
| LABELER NAME: | Perrigo New York Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 205.5(ug/1) |
| START MARKETING DATE: | 2014-05-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45802-026_b2418340-efeb-45a7-bdb4-0f8771f0eb11 |
| PRODUCT NDC: | 45802-026 |
| APPLICATION NUMBER: | ANDA202743 |
Other AZELASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
